SeaStar Medical Holding (ICU) Other Non-Current Liabilities (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Other Non-Current Liabilities came in at $1000.0 in Q4 2025, down 96.97% YoY from $33000.0 in Q4 2024, and little changed on a QoQ basis from $1000.0 in Q3 2025.
SeaStar Medical Holding (ICU) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Other Non-Current Liabilities data on file, last reported at $1000.0 in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 96.97% year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 96.97% YoY) and the FY2025 annual result came in at $1000.0, down 96.97% from the prior year.
- Other Non-Current Liabilities held at $1000.0 in Q4 2025, from $1000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $8.1 million in Q2 2021 to a low of $1000.0 in Q3 2025.
- A 5-year average of $2.8 million and a median of $1.8 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 47.05% — and 2024, when it sank 98.57%.
- Tracing ICU's Other Non-Current Liabilities over 5 years: stood at $55000.0 in 2021, then soared by 1953.41% to $1.1 million in 2022, then surged by 104.27% to $2.3 million in 2023, then slumped by 98.57% to $33000.0 in 2024, then sank by 96.97% to $1000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $1000.0 (Q4 2025), $1000.0 (Q3 2025), and $33000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 7.41 Mn |
| Jun 30, 2021 | 8.06 Mn |
| Mar 31, 2021 | 6.29 Mn |